{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/import-licenses-for-investigational-products-and-biological-samples”
},
“@id”: “https://www.clinicalstudies.in/import-licenses-for-investigational-products-and-biological-samples”,
“headline”: “SOP for Import Licenses for Investigational Products and Biological Samples”,
“name”: “SOP for Import Licenses for Investigational Products and Biological Samples”,
“description”: “Detailed SOP describing procedures for obtaining, maintaining, and managing import licenses for investigational products (IP) and biological samples for clinical trials in Brazil under ANVISA regulation.”,
“keywords”: “import license SOP Brazil, clinical trial import permits ANVISA, SOP for IP import Brazil, SOP for biological sample import Brazil, ANVISA import/export SOP, SOP for trial supply licenses Brazil, clinical trial material import SOP, SOP for ANVISA customs clearance, SOP for CRO import management, investigator responsibilities import Brazil, SOP for sponsor obligations import licenses, SOP for Brazilian trial governance, ANVISA IP import requirements, SOP for import documentation Brazil, SOP for site supply import Brazil, inspection readiness SOP import Brazil, SOP for import license tracker, regulatory compliance SOP Brazil, SOP for IP shipping licenses, biological material customs SOP Brazil, SOP for supply chain Brazil trials, ANVISA licensing SOP, SOP for shipment approval Brazil, SOP for IP regulatory submissions Brazil, SOP for import coordination Brazil”,
“articleSection”: “Standard Operating Procedure”,
“datePublished”: “2025-08-28”,
“dateModified”: “2025-08-28”,
“author”: { “@type”: “Organization”, “name”: “Clinicalstudies.in” },
“publisher”: {
“@type”: “Organization”,
“name”: “Clinicalstudies.in”,
“logo”: { “@type”: “ImageObject”, “url”: “https://www.clinicalstudies.in/logo.png” }
}
}

Import Licenses for Investigational Products and Biological Samples SOP

Purpose

The purpose of this SOP is to define the process for obtaining, maintaining, and managing import licenses for investigational products (IP) and biological samples for use in clinical trials conducted in Brazil. This ensures compliance with ANVISA regulations and Brazilian customs laws, while safeguarding supply chain integrity and trial continuity.

Scope

This SOP applies to all sponsor-initiated clinical trials in Brazil that require the importation of investigational medicinal products (IMPs), comparators, placebos, and biological samples for analysis. It covers license applications, renewals, customs clearance, CRO/vendor responsibilities, and documentation archiving. It applies to sponsors, investigators, CROs, and regulatory affairs teams.

Responsibilities

• Sponsor: Ensures valid import licenses are obtained before shipment of IPs or samples.
• Regulatory Affairs (RA): Prepares and submits license applications to ANVISA and coordinates renewals.
• Logistics Manager: Ensures shipments are aligned with import permits and maintains supply chain records.
• Principal Investigator (PI): Confirms receipt of imported materials at site and ensures storage per protocol.
• Quality Assurance (QA): Audits import license documentation for inspection readiness.
• CRO: Supports application and manages interactions with customs when delegated.

Accountability

The Sponsor’s Head of Regulatory Affairs is accountable for ensuring compliance with import license requirements. The PI is accountable for proper handling and documentation of imported trial materials at the site.

Procedure

1. Pre-Import Assessment

1. Determine whether investigational products or samples require import licenses under ANVISA rules.
2. Document requirements in Import Assessment Form (Annexure-1).

2. License Application

1. Prepare application dossier including protocol, IP details, MSDS, GMP certificate, and import justification.
2. Submit dossier electronically to ANVISA.
3. Record application details in Import License Submission Log.

3. Customs Clearance and Shipment

1. Ensure shipments align with approved license and contain correct labeling.
2. Maintain Import Shipment Tracker with details of customs clearance dates, reference numbers, and responsible parties.

4. Renewal of Licenses

1. Monitor expiry dates of licenses and initiate renewal process 60 days before expiration.
2. Submit updated protocol and supply chain details if required.

5. Documentation and Archiving

1. File import permits, customs clearance receipts, and correspondence in TMF.
2. Archive records for 15 years or per ANVISA requirements.

Abbreviations

• ANVISA: Agência Nacional de Vigilância Sanitária
• IP: Investigational Product
• IMP: Investigational Medicinal Product
• MSDS: Material Safety Data Sheet
• PI: Principal Investigator
• RA: Regulatory Affairs
• QA: Quality Assurance
• TMF: Trial Master File
• CRO: Contract Research Organization

Documents

1. Import Assessment Form (Annexure-1)
2. Import License Submission Log (Annexure-2)
3. Import Shipment Tracker (Annexure-3)

References

• ANVISA — Clinical Trial Imports
• ICH E6(R2) Good Clinical Practice
• ICH Quality Guidelines

Version: 1.0

Approval

Annexures

Annexure-1: Import Assessment Form

Annexure-2: Import License Submission Log

Annexure-3: Import Shipment Tracker

Revision History

For more SOPs visit: Pharma SOP.

{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/dual-approvals-coordination”
},
“@id”: “https://www.clinicalstudies.in/dual-approvals-coordination”,
“headline”: “SOP for Dual Approvals Coordination”,
“name”: “SOP for Dual Approvals Coordination”,
“description”: “Comprehensive SOP for coordinating dual approvals from CONEP (National Ethics Commission) and ANVISA (National Health Surveillance Agency) in Brazil, ensuring timely clinical trial governance and compliance.”,
“keywords”: “ANVISA clinical trial SOP, dual approvals CONEP ANVISA, Brazilian regulatory SOP, SOP for CONEP coordination, ANVISA trial governance, SOP for ethics and regulatory approvals Brazil, CONEP ANVISA submission workflow, SOP for dual approval timelines, regulatory compliance SOP Brazil, SOP for sponsor obligations Brazil, ANVISA inspection readiness SOP, SOP for clinical trial governance Brazil, dual submission SOP Brazil, SOP for trial lifecycle ANVISA, SOP for CONEP site ethics Brazil, SOP for clinical trial sponsor Brazil, regulatory approval log Brazil, SOP for trial start-up Brazil, ethics compliance SOP Brazil, SOP for document submissions ANVISA, SOP for investigator responsibilities Brazil, SOP for ANVISA CTA submissions, SOP for CONEP approvals, SOP for CRO coordination Brazil, SOP for dual governance clinical trials”,
“articleSection”: “Standard Operating Procedure”,
“datePublished”: “2025-08-28”,
“dateModified”: “2025-08-28”,
“author”: { “@type”: “Organization”, “name”: “Clinicalstudies.in” },
“publisher”: {
“@type”: “Organization”,
“name”: “Clinicalstudies.in”,
“logo”: { “@type”: “ImageObject”, “url”: “https://www.clinicalstudies.in/logo.png” }
}
}

Dual Approvals Coordination SOP

Purpose

This SOP establishes procedures for coordinating dual approvals required from CONEP (National Commission for Ethics in Research) and ANVISA (National Health Surveillance Agency) for clinical trials in Brazil. It ensures alignment of ethics and regulatory approvals for timely trial initiation and compliance with Brazilian law and ICH GCP.

Scope

This SOP applies to all sponsor-initiated clinical trials in Brazil requiring simultaneous or sequential approvals from CONEP and ANVISA. It covers initial Clinical Trial Application (CTA), ethics submissions, amendments, safety reporting, and ongoing lifecycle obligations. It applies to sponsors, CROs, investigators, and regulatory affairs teams.

Responsibilities

• Sponsor: Prepares submission dossiers for both CONEP and ANVISA and ensures approvals are secured prior to trial initiation.
• Regulatory Affairs (RA): Manages the dual submission process, ensures communication consistency, and tracks timelines.
• Principal Investigator (PI): Provides site-specific documentation and ensures site compliance with CONEP and ANVISA approvals.
• Clinical Project Manager (CPM): Coordinates timelines and ensures approvals are documented in TMF.
• Quality Assurance (QA): Audits approval packages and ensures readiness for ANVISA inspections.

Accountability

The Sponsor’s Head of Regulatory Affairs is accountable for ensuring accurate and timely submissions to CONEP and ANVISA. The PI is accountable for site-level adherence to dual approval requirements.

Procedure

1. Preparation of Submission Packages

1. Compile CTA package for ANVISA, including protocol, Investigator’s Brochure (IB), investigational product information, and GMP certificates.
2. Prepare ethics submission package for CONEP including protocol, ICFs, recruitment materials, and investigator CVs.

2. Submission Process

1. Submit ethics dossier to CONEP via Plataforma Brasil.
2. Submit CTA dossier to ANVISA through the electronic submission portal.
3. Record submission acknowledgments in Dual Approvals Submission Log.

3. Coordination of Approvals

1. Monitor timelines to ensure both CONEP and ANVISA approvals are received before trial initiation.
2. Communicate with both authorities regarding queries or requests for additional information.

4. Amendments

1. Submit substantial amendments simultaneously to CONEP and ANVISA.
2. Document approvals in Amendment Log.

5. Safety Reporting

1. Submit SUSARs and DSURs to both CONEP and ANVISA as per timelines.
2. File acknowledgment receipts in TMF and ISF.

6. Documentation and Archiving

1. Maintain submission logs, approval letters, and acknowledgments in TMF.
2. Archive documents for at least 15 years or per Brazilian requirements.

Abbreviations

• ANVISA: Agência Nacional de Vigilância Sanitária
• CONEP: Comissão Nacional de Ética em Pesquisa
• CTA: Clinical Trial Application
• IB: Investigator’s Brochure
• ICF: Informed Consent Form
• PI: Principal Investigator
• RA: Regulatory Affairs
• QA: Quality Assurance
• CPM: Clinical Project Manager
• TMF: Trial Master File
• ISF: Investigator Site File

Documents

1. Dual Approvals Submission Log (Annexure-1)
2. Amendment Log (Annexure-2)
3. Approval Tracker (Annexure-3)

References

• ANVISA — National Health Surveillance Agency
• CONEP — National Commission for Ethics in Research
• ICH E6(R2) Good Clinical Practice

Version: 1.0

Approval

Annexures

Annexure-1: Dual Approvals Submission Log

Annexure-2: Amendment Log

Annexure-3: Approval Tracker

Revision History

For more SOPs visit: Pharma SOP.